Product Description
The prefilled syringe is a relative newcomer to the syringe market. It can increase accuracy in dosing, since medicine in the prefilled syringe is expected to be the same with each dose. There are now many vaccines that are available in prefilled forms and some medicines for home use also are obtainable, which many feel helps takes some of the guesswork out of home injections for people who must self-inject medications.
The Pre-Filled Syringes market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Pre-Filled Syringes market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Pre-Filled Syringes Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Pre-Filled Syringes market are:
Weigao Group
Nipro Corporation
Catalent, Inc.
Gerresheimer AG
MedPro Inc.
SCHOTT AG
Becton
Ompi
Vetter Pharma International GmbH
West Pharmaceutical Services, Inc.
Dickinson and Company
Most important types of Pre-Filled Syringes products covered in this report are:
Glass
Plastic
Most widely used downstream fields of Pre-Filled Syringes market covered in this report are:
Hospitals
Mail Order Pharmacies
Ambulatory Surgery Centers
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.